1 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Lixte stock soars on preclinical data for lead drug LB-100 https://seekingalpha.com/news/4084596-lixte-stock-soars-on-preclinical-data-for-lead-drug-lb-100?source=feed_sector_healthcare Mar 27, 2024 - Lixte (LIXT) stock was up nearly 60% Wednesday after the company reported the publication of positive preclinical data for its lead clinical asset LB-100. Read more here.

Pages: 1

Page 1